|
By Mark Blaxill As we enter the heart of flu season, industry pressure to rehabilitate thimerosal (the ethyl mercury-based vaccine preservative) has been escalating. Just last week, The Wall Street Journal ran an opinion piece blaming swine flu vaccine shortages...
|
Write a comment:
|